2023-11-24 |
2023-11-22 |
S
Sale
|
ORBIMED ADVISORS LLC
Large shareholder
|
87,786
-100.0%
2.23
195,763
USD
|
87,786
-100.0%
|
2.23
|
195,763
USD
|
|
2023-09-18 |
2023-09-15 |
S
Sale
|
Alland Leila
Chief Medical Officer
Officer
|
6,291
-12.1%
6.62
41,646
USD
|
6,291
-12.1%
|
6.62
|
41,646
USD
|
|
2023-09-18 |
2023-09-15 |
S
Sale
|
Jalota Deepika
Chief Development Officer
Officer
|
4,104
-12.1%
6.62
27,168
USD
|
4,104
-12.1%
|
6.62
|
27,168
USD
|
|
2022-05-31 |
2022-05-26 |
S
Sale
|
ORBIMED ADVISORS LLC
Large shareholder
|
26,253
-23.0%
15.93
418,210
USD
|
26,253
-23.0%
|
15.93
|
418,210
USD
|
|
2021-10-08 |
2021-10-06 |
PS
Planned sale
|
Schroeder Thilo
Non-Executive Director
|
800
-0.1%
30.15
24,120
USD
|
800
-0.1%
|
30.15
|
24,120
USD
|
|
2021-10-04 |
2021-10-04 |
PS
Planned sale
|
Schroeder Thilo
Non-Executive Director
|
100
-0.0%
30.08
3,008
USD
|
100
-0.0%
|
30.08
|
3,008
USD
|
|
2021-10-04 |
2021-10-01 |
PS
Planned sale
|
Schroeder Thilo
Non-Executive Director
|
11,541
-1.0%
30.10
347,384
USD
|
11,541
-1.0%
|
30.10
|
347,384
USD
|
|
2021-10-04 |
2021-09-30 |
PS
Planned sale
|
Schroeder Thilo
Non-Executive Director
|
2,978
-0.3%
30.03
89,429
USD
|
2,978
-0.3%
|
30.03
|
89,429
USD
|
|
2021-09-29 |
2021-09-29 |
PS
Planned sale
|
Schroeder Thilo
Non-Executive Director
|
5,708
-0.5%
30.04
171,468
USD
|
5,708
-0.5%
|
30.04
|
171,468
USD
|
|
2021-09-29 |
2021-09-27 |
PS
Planned sale
|
Schroeder Thilo
Non-Executive Director
|
1,753
-0.2%
30.11
52,783
USD
|
1,753
-0.2%
|
30.11
|
52,783
USD
|
|
2021-09-13 |
2021-09-13 |
PS
Planned sale
|
Schroeder Thilo
Non-Executive Director
|
13,272
-1.2%
30.20
400,814
USD
|
13,272
-1.2%
|
30.20
|
400,814
USD
|
|
2021-09-13 |
2021-09-10 |
PS
Planned sale
|
Schroeder Thilo
Non-Executive Director
|
5,171
-0.5%
31.03
160,456
USD
|
5,171
-0.5%
|
31.03
|
160,456
USD
|
|
2021-09-13 |
2021-09-10 |
PS
Planned sale
|
Schroeder Thilo
Non-Executive Director
|
38,056
-3.2%
30.44
1,158,425
USD
|
38,056
-3.2%
|
30.44
|
1,158,425
USD
|
|
2021-09-13 |
2021-09-09 |
PS
Planned sale
|
Schroeder Thilo
Non-Executive Director
|
14,329
-1.2%
30.31
434,312
USD
|
14,329
-1.2%
|
30.31
|
434,312
USD
|
|
2021-08-20 |
2021-08-19 |
PS
Planned sale
|
Schroeder Thilo
Non-Executive Director
|
3,800
-0.2%
30.97
117,686
USD
|
3,800
-0.2%
|
30.97
|
117,686
USD
|
|
2021-08-20 |
2021-08-18 |
PS
Planned sale
|
Schroeder Thilo
Non-Executive Director
|
2,237
-0.1%
34.32
76,774
USD
|
2,237
-0.1%
|
34.32
|
76,774
USD
|
|
2021-08-20 |
2021-08-18 |
PS
Planned sale
|
Schroeder Thilo
Non-Executive Director
|
13,196
-0.8%
33.84
446,553
USD
|
13,196
-0.8%
|
33.84
|
446,553
USD
|
|
2021-08-20 |
2021-08-18 |
PS
Planned sale
|
Schroeder Thilo
Non-Executive Director
|
11,431
-0.7%
32.57
372,308
USD
|
11,431
-0.7%
|
32.57
|
372,308
USD
|
|
2021-08-04 |
2021-08-03 |
PS
Planned sale
|
Kung Winston
COO, CFO
Officer
|
4,500
-73.8%
33.82
152,178
USD
|
4,500
-73.8%
|
33.82
|
152,178
USD
|
|
2021-07-08 |
2021-07-08 |
PS
Planned sale
|
Kung Winston
COO, CFO
Officer
|
4,500
-73.8%
33.75
151,875
USD
|
4,500
-73.8%
|
33.75
|
151,875
USD
|
|
2021-06-29 |
2021-06-28 |
PS
Planned sale
|
Mack David Henry
President and CEO
Executive Director
|
204
-1.6%
35.53
7,248
USD
|
204
-1.6%
|
35.53
|
7,248
USD
|
|
2021-06-15 |
2021-06-14 |
S
Sale
|
Euclidean Capital LLC
Large shareholder
|
1,260
-1.0%
34.11
42,979
USD
|
1,260
-1.0%
|
34.11
|
42,979
USD
|
|
2021-06-15 |
2021-06-14 |
S
Sale
|
Euclidean Capital LLC
Large shareholder
|
24,726
-1.0%
34.11
843,404
USD
|
24,726
-1.0%
|
34.11
|
843,404
USD
|
|
2021-06-15 |
2021-06-14 |
S
Sale
|
Euclidean Capital LLC
Large shareholder
|
7,141
-1.0%
34.11
243,580
USD
|
7,141
-1.0%
|
34.11
|
243,580
USD
|
|
2021-06-15 |
2021-06-14 |
S
Sale
|
Euclidean Capital LLC
Large shareholder
|
6,593
-1.0%
34.11
224,887
USD
|
6,593
-1.0%
|
34.11
|
224,887
USD
|
|
2021-06-15 |
2021-06-14 |
S
Sale
|
Euclidean Capital LLC
Large shareholder
|
4,699
-1.0%
34.11
160,283
USD
|
4,699
-1.0%
|
34.11
|
160,283
USD
|
|
2021-06-15 |
2021-06-11 |
S
Sale
|
Euclidean Capital LLC
Large shareholder
|
621
-0.5%
33.80
20,990
USD
|
621
-0.5%
|
33.80
|
20,990
USD
|
|
2021-06-15 |
2021-06-11 |
S
Sale
|
Euclidean Capital LLC
Large shareholder
|
12,237
-0.5%
33.80
413,611
USD
|
12,237
-0.5%
|
33.80
|
413,611
USD
|
|
2021-06-15 |
2021-06-11 |
S
Sale
|
Euclidean Capital LLC
Large shareholder
|
3,533
-0.5%
33.80
119,415
USD
|
3,533
-0.5%
|
33.80
|
119,415
USD
|
|
2021-06-15 |
2021-06-11 |
S
Sale
|
Euclidean Capital LLC
Large shareholder
|
3,262
-0.5%
33.80
110,256
USD
|
3,262
-0.5%
|
33.80
|
110,256
USD
|
|
2021-06-15 |
2021-06-11 |
S
Sale
|
Euclidean Capital LLC
Large shareholder
|
2,324
-0.5%
33.80
78,551
USD
|
2,324
-0.5%
|
33.80
|
78,551
USD
|
|
2021-06-11 |
2021-06-10 |
S
Sale
|
Euclidean Capital LLC
Large shareholder
|
585
-0.4%
32.68
19,118
USD
|
585
-0.4%
|
32.68
|
19,118
USD
|
|
2021-06-11 |
2021-06-10 |
S
Sale
|
Euclidean Capital LLC
Large shareholder
|
11,485
-0.5%
32.68
375,330
USD
|
11,485
-0.5%
|
32.68
|
375,330
USD
|
|
2021-06-11 |
2021-06-10 |
S
Sale
|
Euclidean Capital LLC
Large shareholder
|
3,317
-0.5%
32.68
108,400
USD
|
3,317
-0.5%
|
32.68
|
108,400
USD
|
|
2021-06-11 |
2021-06-10 |
S
Sale
|
Euclidean Capital LLC
Large shareholder
|
3,063
-0.5%
32.68
100,099
USD
|
3,063
-0.5%
|
32.68
|
100,099
USD
|
|
2021-06-11 |
2021-06-10 |
S
Sale
|
Euclidean Capital LLC
Large shareholder
|
2,183
-0.5%
32.68
71,340
USD
|
2,183
-0.5%
|
32.68
|
71,340
USD
|
|
2021-06-11 |
2021-06-09 |
S
Sale
|
Euclidean Capital LLC
Large shareholder
|
1,121
-0.9%
33.64
37,710
USD
|
1,121
-0.9%
|
33.64
|
37,710
USD
|
|
2021-06-11 |
2021-06-09 |
S
Sale
|
Euclidean Capital LLC
Large shareholder
|
22,070
-0.9%
33.64
742,435
USD
|
22,070
-0.9%
|
33.64
|
742,435
USD
|
|
2021-06-11 |
2021-06-09 |
S
Sale
|
Euclidean Capital LLC
Large shareholder
|
6,372
-0.9%
33.64
214,354
USD
|
6,372
-0.9%
|
33.64
|
214,354
USD
|
|
2021-06-11 |
2021-06-09 |
S
Sale
|
Euclidean Capital LLC
Large shareholder
|
5,883
-0.9%
33.64
197,904
USD
|
5,883
-0.9%
|
33.64
|
197,904
USD
|
|
2021-06-11 |
2021-06-09 |
S
Sale
|
Euclidean Capital LLC
Large shareholder
|
4,192
-0.9%
33.64
141,019
USD
|
4,192
-0.9%
|
33.64
|
141,019
USD
|
|
2021-06-09 |
2021-06-08 |
S
Sale
|
Euclidean Capital LLC
Large shareholder
|
896
-0.7%
33.38
29,908
USD
|
896
-0.7%
|
33.38
|
29,908
USD
|
|
2021-06-09 |
2021-06-08 |
S
Sale
|
Euclidean Capital LLC
Large shareholder
|
17,664
-0.7%
33.38
589,624
USD
|
17,664
-0.7%
|
33.38
|
589,624
USD
|
|
2021-06-09 |
2021-06-08 |
S
Sale
|
Euclidean Capital LLC
Large shareholder
|
5,101
-0.7%
33.38
170,271
USD
|
5,101
-0.7%
|
33.38
|
170,271
USD
|
|
2021-06-09 |
2021-06-08 |
S
Sale
|
Euclidean Capital LLC
Large shareholder
|
4,708
-0.7%
33.38
157,153
USD
|
4,708
-0.7%
|
33.38
|
157,153
USD
|
|
2021-06-09 |
2021-06-08 |
S
Sale
|
Euclidean Capital LLC
Large shareholder
|
3,355
-0.7%
33.38
111,990
USD
|
3,355
-0.7%
|
33.38
|
111,990
USD
|
|
2021-06-09 |
2021-06-07 |
S
Sale
|
Euclidean Capital LLC
Large shareholder
|
1,019
-0.8%
33.62
34,259
USD
|
1,019
-0.8%
|
33.62
|
34,259
USD
|
|
2021-06-09 |
2021-06-07 |
S
Sale
|
Euclidean Capital LLC
Large shareholder
|
16,901
-0.6%
33.62
568,212
USD
|
16,901
-0.6%
|
33.62
|
568,212
USD
|
|
2021-06-09 |
2021-06-07 |
S
Sale
|
Euclidean Capital LLC
Large shareholder
|
4,946
-0.7%
33.62
166,285
USD
|
4,946
-0.7%
|
33.62
|
166,285
USD
|
|
2021-06-09 |
2021-06-07 |
S
Sale
|
Euclidean Capital LLC
Large shareholder
|
4,564
-0.7%
33.62
153,442
USD
|
4,564
-0.7%
|
33.62
|
153,442
USD
|
|
2021-06-09 |
2021-06-07 |
S
Sale
|
Euclidean Capital LLC
Large shareholder
|
3,291
-0.7%
33.62
110,643
USD
|
3,291
-0.7%
|
33.62
|
110,643
USD
|
|
2021-06-08 |
2021-06-07 |
PS
Planned sale
|
Alland Leila
Chief Medical Officer
Officer
|
1,367
-100.0%
34.00
46,484
USD
|
1,367
-100.0%
|
34.00
|
46,484
USD
|
|
2021-06-08 |
2021-06-07 |
PS
Planned sale
|
Alland Leila
Chief Medical Officer
Officer
|
2,633
-65.8%
33.39
87,903
USD
|
2,633
-65.8%
|
33.39
|
87,903
USD
|
|
2021-06-07 |
2021-06-04 |
PS
Planned sale
|
Kung Winston
COO, CFO
Officer
|
4,500
-73.8%
33.75
151,875
USD
|
4,500
-73.8%
|
33.75
|
151,875
USD
|
|
2021-06-02 |
2021-06-01 |
PS
Planned sale
|
Heyman Richard A.
Non-Executive Director
|
2
-100.0%
34.67
69
USD
|
2
-100.0%
|
34.67
|
69
USD
|
|
2021-06-02 |
2021-06-01 |
PS
Planned sale
|
Heyman Richard A.
Non-Executive Director
|
209
-99.1%
33.79
7,062
USD
|
209
-99.1%
|
33.79
|
7,062
USD
|
|
2021-06-02 |
2021-06-01 |
PS
Planned sale
|
Heyman Richard A.
Non-Executive Director
|
764
-78.4%
32.15
24,563
USD
|
764
-78.4%
|
32.15
|
24,563
USD
|
|
2021-06-02 |
2021-06-01 |
PS
Planned sale
|
Heyman Richard A.
Non-Executive Director
|
2
-100.0%
34.67
69
USD
|
2
-100.0%
|
34.67
|
69
USD
|
|
2021-06-02 |
2021-06-01 |
PS
Planned sale
|
Heyman Richard A.
Non-Executive Director
|
230
-99.1%
33.75
7,762
USD
|
230
-99.1%
|
33.75
|
7,762
USD
|
|
2021-06-02 |
2021-06-01 |
PS
Planned sale
|
Heyman Richard A.
Non-Executive Director
|
743
-76.2%
32.16
23,896
USD
|
743
-76.2%
|
32.16
|
23,896
USD
|
|
2021-06-02 |
2021-06-01 |
PS
Planned sale
|
Heyman Richard A.
Non-Executive Director
|
5
-100.0%
34.67
173
USD
|
5
-100.0%
|
34.67
|
173
USD
|
|
2021-06-02 |
2021-06-01 |
PS
Planned sale
|
Heyman Richard A.
Non-Executive Director
|
553
-99.1%
33.61
18,587
USD
|
553
-99.1%
|
33.61
|
18,587
USD
|
|
2021-06-02 |
2021-06-01 |
PS
Planned sale
|
Heyman Richard A.
Non-Executive Director
|
1,392
-71.4%
32.15
44,754
USD
|
1,392
-71.4%
|
32.15
|
44,754
USD
|
|
2021-06-02 |
2021-05-28 |
PS
Planned sale
|
Schroeder Thilo
Non-Executive Director
|
5,100
-0.2%
35.80
182,580
USD
|
5,100
-0.2%
|
35.80
|
182,580
USD
|
|
2021-05-24 |
2021-05-21 |
PS
Planned sale
|
Mack David Henry
President and CEO
Executive Director
|
6,207
-71.5%
35.71
221,641
USD
|
6,207
-71.5%
|
35.71
|
221,641
USD
|
|
2021-05-24 |
2021-05-20 |
PS
Planned sale
|
Mack David Henry
President and CEO
Executive Director
|
7,793
-75.9%
35.60
277,455
USD
|
7,793
-75.9%
|
35.60
|
277,455
USD
|
|
2021-05-10 |
2021-05-07 |
PS
Planned sale
|
Alland Leila
Chief Medical Officer
Officer
|
158
-100.0%
35.49
5,607
USD
|
158
-100.0%
|
35.49
|
5,607
USD
|
|
2021-05-10 |
2021-05-07 |
PS
Planned sale
|
Alland Leila
Chief Medical Officer
Officer
|
3,842
-96.0%
34.80
133,702
USD
|
3,842
-96.0%
|
34.80
|
133,702
USD
|
|
2021-05-07 |
2021-05-05 |
PS
Planned sale
|
Schroeder Thilo
Non-Executive Director
|
600
-0.0%
35.64
21,384
USD
|
600
-0.0%
|
35.64
|
21,384
USD
|
|
2021-05-04 |
2021-05-03 |
PS
Planned sale
|
Kung Winston
COO, CFO
Officer
|
4,500
-73.8%
33.75
151,875
USD
|
4,500
-73.8%
|
33.75
|
151,875
USD
|
|
2021-04-13 |
2021-04-12 |
PS
Planned sale
|
Schroeder Thilo
Non-Executive Director
|
100
-0.0%
33.11
3,311
USD
|
100
-0.0%
|
33.11
|
3,311
USD
|
|
2021-04-13 |
2021-04-12 |
PS
Planned sale
|
Schroeder Thilo
Non-Executive Director
|
900
-0.0%
32.00
28,800
USD
|
900
-0.0%
|
32.00
|
28,800
USD
|
|
2021-04-13 |
2021-04-12 |
PS
Planned sale
|
Schroeder Thilo
Non-Executive Director
|
2,903
-0.1%
31.17
90,487
USD
|
2,903
-0.1%
|
31.17
|
90,487
USD
|
|
2021-04-13 |
2021-04-09 |
PS
Planned sale
|
Schroeder Thilo
Non-Executive Director
|
19,858
-0.9%
34.89
692,846
USD
|
19,858
-0.9%
|
34.89
|
692,846
USD
|
|
2021-04-13 |
2021-04-09 |
PS
Planned sale
|
Schroeder Thilo
Non-Executive Director
|
5,905
-0.3%
33.75
199,294
USD
|
5,905
-0.3%
|
33.75
|
199,294
USD
|
|